Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Zanamivir

Catalog No. T2529Cas No. 139110-80-8
Alias GG167

Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.

Zanamivir

Zanamivir

Purity: 99.98%
Catalog No. T2529Alias GG167Cas No. 139110-80-8
Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Pack SizePriceAvailabilityQuantity
5 mg$45In Stock
10 mg$72In Stock
25 mg$112In Stock
50 mg$157In Stock
100 mg$273In Stock
200 mg$397In Stock
1 mL x 10 mM (in DMSO)$56In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Zanamivir"

Select Batch
Purity:99.98%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Zanamivir (GG167) is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Targets&IC50
Influenza A:0.95 nM, Influenza B:2.7 nM
In vitro
Zanamivir reduces pulmonary viral titers and decreases morbidity and mortality rates in a lethal murine model infected with the virus.
In vivo
Zanamivir effectively reduces viral replication in vitro by inhibiting the influenza neuraminidase and preventing the cleavage of sialic acid residues. This interference blocks the spread of progeny viruses in mucosal secretions and lowers viral infectivity. Furthermore, Zanamivir diminishes the area of plaques formed by neuraminidase-deficient mutants, indicating that its action in disrupting cell-cell fusion is independent of its neuraminidase inhibition activity. The compound also prevents the adhesion and fusion of persistently infected cells with uninfected erythrocytes. Assessment through lipid mixing and content mixing reveals that Zanamivir does not affect erythrocyte adhesion but does inhibit HA2b-red blood cell fusion. Additionally, Zanamivir leads to decreased sensitivity in influenza A/H1N1 variants His274Asn, His274 gly, His274Ser, and His274 gln.
AliasGG167
Chemical Properties
Molecular Weight332.31
FormulaC12H20N4O7
Cas No.139110-80-8
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 10 mg/mL (30.09 mM), Sonication and heating are recommended.
DMSO: <1 mg/mL (Insoluble)
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM3.0092 mL15.0462 mL30.0924 mL150.4619 mL
5 mM0.6018 mL3.0092 mL6.0185 mL30.0924 mL
10 mM0.3009 mL1.5046 mL3.0092 mL15.0462 mL
20 mM0.1505 mL0.7523 mL1.5046 mL7.5231 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zanamivir | purchase Zanamivir | Zanamivir cost | order Zanamivir | Zanamivir chemical structure | Zanamivir in vivo | Zanamivir in vitro | Zanamivir formula | Zanamivir molecular weight